[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Short Bowel Syndrome Market Size, Trends, Analysis, and Outlook By Drug Class (GLP-2, Growth Hormone, Glutamine, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), by Region, Country, Segment, and Companies, 2024-2030

March 2024 | 190 pages | ID: S2F065E8B283EN
VPAResearch

US$ 3,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Short Bowel Syndrome market size is poised to register 19.8% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Short Bowel Syndrome market By Drug Class (GLP-2, Growth Hormone, Glutamine, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others).

The future of short bowel syndrome (SBS) management is evolving with key trends aimed at improving nutritional support, intestinal adaptation, and quality of life for individuals with this complex gastrointestinal disorder. One significant trend is the development of innovative parenteral and enteral nutrition formulations, including specialized amino acid-based formulas, lipid emulsions, and prebiotic/probiotic supplements, tailored to the unique nutrient requirements, absorptive capacity, and digestive physiology of patients with SBS, to optimize nutritional intake, minimize malabsorption, and support mucosal healing and intestinal function. Additionally, there is a growing emphasis on multidisciplinary care models, intestinal rehabilitation programs, and surgical interventions, such as bowel lengthening procedures, intestinal transplantation, and intestinal autotransplantation, that aim to enhance intestinal adaptation, reduce dependency on parenteral nutrition, and improve long-term outcomes for individuals with SBS. Moreover, advancements in intestinal tissue engineering, stem cell therapy, and regenerative medicine hold promise for future treatments that promote intestinal growth, mucosal repair, and functional restoration in patients with SBS, offering potential alternatives to conventional therapies and improving the prognosis for individuals with this challenging condition. Furthermore, there is increasing recognition of the importance of patient-centered care, psychosocial support, and shared decision-making in SBS management, with efforts focused on addressing the physical, emotional, and social aspects of living with a chronic gastrointestinal disorder and empowering patients to actively participate in their treatment journey. Overall, the future of SBS management holds promise for continued innovation in nutritional support, intestinal rehabilitation, and therapeutic strategies, fostering improved outcomes and quality of life for individuals affected by this rare and challenging condition..

Short Bowel Syndrome Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Short Bowel Syndrome market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Short Bowel Syndrome survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Short Bowel Syndrome industry.

Key market trends defining the global Short Bowel Syndrome demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Short Bowel Syndrome Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Short Bowel Syndrome industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Short Bowel Syndrome companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Short Bowel Syndrome industry

Leading Short Bowel Syndrome companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Short Bowel Syndrome companies.

Short Bowel Syndrome Market Study- Strategic Analysis Review

The Short Bowel Syndrome market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
  • Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
  • Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
  • Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
  • Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Short Bowel Syndrome Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Short Bowel Syndrome industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Short Bowel Syndrome Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Short Bowel Syndrome Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Short Bowel Syndrome market segments. Similarly, Strong end-user demand is encouraging Canadian Short Bowel Syndrome companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Short Bowel Syndrome market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Short Bowel Syndrome Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Short Bowel Syndrome industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Short Bowel Syndrome market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Short Bowel Syndrome Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Short Bowel Syndrome in Asia Pacific. In particular, China, India, and South East Asian Short Bowel Syndrome markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Short Bowel Syndrome Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Short Bowel Syndrome Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Short Bowel Syndrome market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Short Bowel Syndrome.

Short Bowel Syndrome Market Company Profiles

The global Short Bowel Syndrome market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are 9 Meters Biopharma, Ardelyx, Hanmi Pharm.Co. Ltd, Merck KGaA, Nestle Health Science, Nutrinia, OPKO Health Inc, OxThera Inc, Sancilio&Company Inc, Takeda Pharmaceutical Company Ltd, VectivBio AG, Zealand Pharma.

Recent Short Bowel Syndrome Market Developments

The global Short Bowel Syndrome market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Short Bowel Syndrome Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • SWOT Profile
  • Market Dynamics- Trends, Drivers, Challenges
  • Porter’s Five Forces Analysis
  • Macroeconomic Impact Analysis
  • Case Scenarios- Low, Base, High
Market Segmentation:

By Type

Stationary 3D and 4D Ultrasound Devices

Portable 3D and 4D Ultrasound Devices

By Display

Color Ultrasound

B/W Ultrasound

By Portability

Trolley or Cart-Based Ultrasound Systems

Compact/Handheld Ultrasound Systems

Point-of-Pare (PoC) Ultrasound Systems

By Application

Radiology or General Imaging

Obstetrics or Gynecology

Cardiology

Urology

Vascular

Orthopedic and Musculoskeletal

Pain Management

Others

By End-User

Hospitals

Surgical Centers and Diagnostic Centers

Maternity Centers

Ambulatory Care Centers

Research and Academia

Others

Geographical Segmentation:
  • North America (3 markets)
  • Europe (6 markets)
  • Asia Pacific (6 markets)
  • Latin America (3 markets)
  • Middle East Africa (5 markets)
Companies

9 Meters Biopharma

Ardelyx

Hanmi Pharm.Co. Ltd

Merck KGaA

Nestle Health Science

Nutrinia

OPKO Health Inc

OxThera Inc

Sancilio&Company Inc

Takeda Pharmaceutical Company Ltd

VectivBio AG

Zealand Pharma

Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY

1.1 Short Bowel Syndrome Market Overview and Key Findings, 2024
1.2 Short Bowel Syndrome Market Size and Growth Outlook, 2021- 2030
1.3 Short Bowel Syndrome Market Growth Opportunities to 2030
1.4 Key Short Bowel Syndrome Market Trends and Challenges
  1.4.1 Short Bowel Syndrome Market Drivers and Trends
  1.4.2 Short Bowel Syndrome Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Short Bowel Syndrome Companies

2. SHORT BOWEL SYNDROME MARKET SIZE OUTLOOK TO 2030

2.1 Short Bowel Syndrome Market Size Outlook, USD Million, 2021- 2030
2.2 Short Bowel Syndrome Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024

3. SHORT BOWEL SYNDROME MARKET- STRATEGIC ANALYSIS REVIEW

3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis

4. SHORT BOWEL SYNDROME MARKET SEGMENTATION ANALYSIS AND OUTLOOK

4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030

5. REGION-WISE MARKET OUTLOOK TO 2030

5.1 Key Findings for Asia Pacific Short Bowel Syndrome Market, 2025
5.2 Asia Pacific Short Bowel Syndrome Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Short Bowel Syndrome Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Short Bowel Syndrome Market, 2025
5.5 Europe Short Bowel Syndrome Market Size Outlook by Type, 2021- 2030
5.6 Europe Short Bowel Syndrome Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Short Bowel Syndrome Market, 2025
5.8 North America Short Bowel Syndrome Market Size Outlook by Type, 2021- 2030
5.9 North America Short Bowel Syndrome Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Short Bowel Syndrome Market, 2025
5.11 South America Pacific Short Bowel Syndrome Market Size Outlook by Type, 2021- 2030
5.12 South America Short Bowel Syndrome Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Short Bowel Syndrome Market, 2025
5.14 Middle East Africa Short Bowel Syndrome Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Short Bowel Syndrome Market Size Outlook by Application, 2021- 2030

6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030

6.1 US Short Bowel Syndrome Market Size Outlook and Revenue Growth Forecasts
6.2 US Short Bowel Syndrome Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Short Bowel Syndrome Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Short Bowel Syndrome Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Short Bowel Syndrome Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Short Bowel Syndrome Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Short Bowel Syndrome Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Short Bowel Syndrome Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Short Bowel Syndrome Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Short Bowel Syndrome Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Short Bowel Syndrome Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Short Bowel Syndrome Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Short Bowel Syndrome Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Short Bowel Syndrome Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Short Bowel Syndrome Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Short Bowel Syndrome Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Short Bowel Syndrome Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Short Bowel Syndrome Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Short Bowel Syndrome Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Short Bowel Syndrome Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Short Bowel Syndrome Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Short Bowel Syndrome Industry Drivers and Opportunities

7. SHORT BOWEL SYNDROME MARKET OUTLOOK ACROSS SCENARIOS

7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case

8. SHORT BOWEL SYNDROME COMPANY PROFILES

8.1 Profiles of Leading Short Bowel Syndrome Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics

9 METERS BIOPHARMA

Ardelyx
Hanmi Pharm.Co. Ltd
Merck KGaA
Nestle Health Science
Nutrinia
OPKO Health Inc
OxThera Inc
Sancilio&Company Inc
Takeda Pharmaceutical Company Ltd
VectivBio AG
Zealand Pharma

9. APPENDIX

9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information


More Publications